EU Agency Calls For Recall Of US-Made Cancer Drugs
A European regulatory agency on Tuesday recommended recalling three cancer drugs manufactured at a Boehringer Ingelheim GmbH subsidiary's facility in the U.S. after an inspection revealed the risk for potential contamination....To view the full article, register now.
Already a subscriber? Click here to view full article